News
FDA Approves Journavx, First-in-Class Non-Opioid Pain Medication for Acute Pain
The FDA has approved Journavx (suzetrigine), a first-in-class non-opioid pain medication for adults experiencing moderate to severe acute pain. Developed by Vertex Pharmaceuticals, Journavx targets sodium channels in the peripheral…
Read MoreMatthew Perry Foundation Launches Addiction Medicine Fellowship at Massachusetts General Hospital
The Matthew Perry Foundation has launched an addiction medicine fellowship at Massachusetts General Hospital, selecting Dr. Sarah “SK” Kler as its first fellow. The program continues Perry’s mission to reduce…
Read More